Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: A cross-sectional survey study.

Van Brunt K, Pedersini R, Rooney J, Corrigan SM.

Diabetes Res Clin Pract. 2016 Dec 18;126:30-42. doi: 10.1016/j.diabres.2016.12.002. [Epub ahead of print]

2.

Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.

Pedersini R, Monteverdi S, Mazziotti G, Amoroso V, Roca E, Maffezzoni F, Vassalli L, Rodella F, Formenti AM, Frara S, Maroldi R, Berruti A, Simoncini E, Giustina A.

Bone. 2017 Jan 16;97:147-152. doi: 10.1016/j.bone.2017.01.013. [Epub ahead of print]

PMID:
28104509
3.
4.

Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature.

Grisanti S, Ferrari VD, Buglione M, Agazzi GM, Liserre R, Poliani L, Buttolo L, Gipponi S, Pedersini R, Consoli F, Panciani P, Roca E, Spena G, Triggiani L, Berruti A; Gruppo Neuro-Oncologico Bresciano..

J Neurosurg Sci. 2016 Sep 28. [Epub ahead of print]

PMID:
27680966
5.

The Burden of Bladder Pain in Five European Countries: A Cross-sectional Study.

Hakimi Z, Houbiers J, Pedersini R, Vietri J.

Urology. 2017 Jan;99:84-91. doi: 10.1016/j.urology.2016.08.038.

6.

Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.

Kondla A, Glaab T, Pedersini R, Lommatzsch M.

Respir Med. 2016 Sep;118:58-64. doi: 10.1016/j.rmed.2016.07.012.

PMID:
27578472
7.

[Italian validation of the Chemotherapy Induced Taste Alteration Scale].

Campagna S, Gonella S, Stuardi M, Sperlinga R, Cerponi M, Olivero M, Giuliano PL, Marchese R, Carnovali E, Pedersini R, Berchialla P, Dimonte V.

Assist Inferm Ric. 2016 Jan-Mar;35(1):22-8. doi: 10.1702/2228.24016. Italian.

PMID:
27183423
8.

HAV & HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries.

Pedersini R, Marano C, De Moerlooze L, Chen L, Vietri J.

Travel Med Infect Dis. 2016 May-Jun;14(3):221-32. doi: 10.1016/j.tmaid.2016.03.008.

9.

Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil.

Pedersini R, Flores NM, Nishikawa AM.

Value Health. 2015 Nov;18(7):A838. doi: 10.1016/j.jval.2015.09.359. No abstract available.

10.

Cross-Country Profile of Adult Caregivers.

Pedersini R, Annunziata K.

Value Health. 2015 Nov;18(7):A739. doi: 10.1016/j.jval.2015.09.2838. No abstract available.

11.

The Burden of Rheumatoid Arthritis in Russia.

Pedersini R, Karateev DE, Vasilescu RS, Alvir JM, Spurden D, Smolen JS.

Value Health. 2015 Nov;18(7):A651. doi: 10.1016/j.jval.2015.09.2344. No abstract available.

12.

Cross-Sectional Survey Study to Understand Behaviours, Thoughts and Perceptions of Mealtime Insulin Usage In Patients With Type 1 and Type 2 Diabetes.

van Brunt K, Corrigan SM, Pedersini R, Warga J.

Value Health. 2015 Nov;18(7):A614. doi: 10.1016/j.jval.2015.09.2136. No abstract available.

13.

Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?

Amoroso V, Petrelli F, Pedersini R, Simoncini EL, Clézardin P, Barni S, Berruti A.

Future Oncol. 2015;11(21):2853-6. doi: 10.2217/fon.15.210. Review. No abstract available.

14.

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

Amoroso V, Generali D, Buchholz T, Cristofanilli M, Pedersini R, Curigliano G, Daidone MG, Di Cosimo S, Dowsett M, Fox S, Harris AL, Makris A, Vassalli L, Ravelli A, Cappelletti MR, Hatzis C, Hudis CA, Pedrazzoli P, Sapino A, Semiglazov V, Von Minckwitz G, Simoncini EL, Jacobs MA, Barry P, Kühn T, Darby S, Hermelink K, Symmans F, Gennari A, Schiavon G, Dogliotti L, Berruti A, Bottini A.

J Natl Cancer Inst Monogr. 2015 May;2015(51):90-6. doi: 10.1093/jncimonographs/lgv023.

15.

Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer?

Amoroso V, Pedersini R, Sharratt P, Vassalli L, Ferrari L, Sigala S, Simoncini E, Berruti A.

J Clin Oncol. 2015 Jan 20;33(3):290. doi: 10.1200/JCO.2014.58.7923. No abstract available.

PMID:
25512451
16.

The Burden Associated with Non-Adherence in European Patients with Depression.

Pedersini R, Kuehl M.

Value Health. 2014 Nov;17(7):A329. doi: 10.1016/j.jval.2014.08.606. No abstract available.

17.

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies.

Berruti A, Amoroso V, Gallo F, Bertaglia V, Simoncini E, Pedersini R, Ferrari L, Bottini A, Bruzzi P, Sormani MP.

J Clin Oncol. 2014 Dec 1;32(34):3883-91. doi: 10.1200/JCO.2014.55.2836. Review.

PMID:
25349292
18.

Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge.

Passarin MG, Sava T, Furlanetto J, Molino A, Nortilli R, Musso AM, Zaninelli M, Franceschi T, Orrico D, Marangoni S, Dealis C, Graiff C, Filippo R, Grisanti S, Simoncini E, Vassalli L, Berruti A, Pedersini R.

Neurol Sci. 2015 Jan;36(1):117-23. doi: 10.1007/s10072-014-1881-7.

PMID:
25022241
19.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group..

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

20.

Visual attention.

Evans KK, Horowitz TS, Howe P, Pedersini R, Reijnen E, Pinto Y, Kuzmova Y, Wolfe JM.

Wiley Interdiscip Rev Cogn Sci. 2011 Sep;2(5):503-14. doi: 10.1002/wcs.127.

PMID:
26302302
Items per page

Supplemental Content

Loading ...
Support Center